Ketamine may shield patients from PTSD after critical care

NCT ID NCT06179485

ENROLLING_BY_INVITATION Disease control Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows about 1,756 adults who were part of a larger trial and received either ketamine or etomidate during emergency intubation. Researchers want to see if ketamine can reduce PTSD symptoms one year later, since it may block the brain's formation of traumatic memories. Participants will complete surveys about PTSD symptoms at 3 and 12 months.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute respiratory failure post-traumatic stress disorder prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE RESPIRATORY FAILURE POST-TRAUMATIC STRESS DISORDER

Contacts and locations

Locations

Denver Health Medical Center

Denver, Colorado, 80204, United States
Hennepin County Medical Center

Minneapolis, Minnesota, 55415, United States
University of Alabama Hospital

Birmingham, Alabama, 35233, United States
University of Colorado Denver

Aurora, Colorado, 80045, United States
Vanderbilt University Medical Center

Nashville, Tennessee, 37203, United States
Wake Forest Baptist Medical Center

Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.